Dr. Nadine Gelbrich is a dedicated medical specialist and researcher currently affiliated with the Universitätsmedizin Greifswald in Greifswald, Germany, where she serves as a Fachärztin (specialist physician) in the Clinic and Polyclinic for Urology. In addition to her clinical responsibilities, Dr. Gelbrich is pursuing advanced academic qualifications, including her habilitation, and holds the title of Fellow of the European Board of Urology (FEBU). Her academic journey began with medical studies at Ernst-Moritz-Arndt-Universität Greifswald, followed by her medical licensure in 2017, and subsequent clinical and research work in urology.

Dr. Gelbrich’s research focuses on the biological effects of cold physical plasma and the proliferative and apoptotic mechanisms in tumor cells, with a particular interest in innovative treatment approaches that may enhance cancer therapeutics. She has contributed to studies exploring combinations of plasma technology with chemotherapeutic agents to augment tumor toxicity and immunogenicity in cancer models, reflecting her engagement in translational cancer research.

Through her combined work in clinical practice, scientific research, and academic advancement, Dr. Gelbrich contributes to the fields of urology and oncological therapy development, supporting improved understanding and treatment strategies for malignancies within her institution and the broader medical community in Germany.